Although progesterone (P4) has been implicated to offer protection against ovarian cancer (OCa), little is known of its mechanism of action. The goal of this study was to identify P4-regulated genes that have anti-OCa action. Three immortalized nontumorigenic human ovarian surface epithelial (HOSE) cell lines and three OCa (OVCA) cell lines were subjected to 5 days of P4 treatment. Transcriptional profiling with a cDNA microarray containing E2400 known genes was used to identify genes (1) whose expression was consistently downregulated in OVCA cell lines compared to HOSE cell lines, and (2) whose expression was restored in OCa cell lines by P4 treatment. From the candidates selected, activating transcription factor-3 (ATF-3), caveolin-1, deleted in liver cancer-1 (DLC-1), and nonmetastatic clone 23 (NM23-H2) were chosen for post hoc functional studies based on their previously reported action as tumor suppressors or apoptosis inducers. Semiquantitative RT-PCR analyses confirmed loss of or reduced transcription of these genes in OVCA cells when compared to HOSE cells and their upregulation following P4 treatment. Hormonal specificity was demonstrated by blockade experiments with a progestin antagonist RU 38486. Ectopic expression of caveolin-1, DLC-1, and NM23-H2 caused growth inhibition in OVCA cell cultures, but not in HOSE cell cultures, while forced expression of ATF-3 suppressed growth in both. Overexpression of AFT-3 also enhanced caspase-3 activity in both HOSE and OVCA cells, whereas ectopic expression of caveolin-1 and DLC-1 only activated this enzyme in OCa cells. In contrast, NM23-H2 overexpression was ineffective in activating caspase-3. Overexpression of any of the four genes in OCa cells reduced softagar colony formation and cell invasiveness. Taken together, we have identified four new P4-regulated,
Introduction
Epithelial ovarian cancers (OCas), which derive from ovarian surface epithelial (OSE) cells, account for more than 90% of ovarian malignancies and have the worst prognosis among gynecological neoplasms. A woman's risk of epithelial OCas is strongly related to her reproductive history (Risch, 1998; Holschneider and Berek, 2000; La Vecchia, 2001; Ho, 2003) . Factors that suppress ovulation, such as pregnancy or use of hormonal contraceptives, have been widely reported to reduce a woman's risk of OCa. In addition to suppression of ovulation, the protective effect of pregnancy may be attributable to exposure of the OSE to high levels of progesterone (P4) (Yen, 1994) . In concordance, a reduction in OCa risk is associated with increased parity (Adami et al., 1994; Salazar-Martinez et al., 1999) and is observed among women with a history of twin pregnancies, possibly due to higher levels of P4 found in maternal circulation during twin pregnancies when compared to singleton pregnancies (TambyRaja and Ratnam, 1981; Thomas et al., 1998) . In contrast, an increase in OCa incidence has been found in women with P4 deficiency (Modan et al., 1998) .
Lower OCa risks are associated with the use of combined estrogen-progestin oral contraceptives or hormone replacement therapies when compared to estrogen-alone formulations (Cramer et al., 1982; Schneider and Birkhausar, 1995) . Lower incidences of OCa have also been reported for women using highpotency progestin than among individuals taking lowpotency progestin (Schildkraut et al., 2002) . At the cellular level, loss of tissue responsiveness to P4 apparently elevates OCa risk. In this regard, loss of heterozygosity at 11q23.3-24.3, which harbors the progesterone receptor (PR) gene locus, is commonly observed in OCa specimens and this genetic alteration is associated with poor prognosis (Gabra et al., 1995 (Gabra et al., , 1996 Davis et al., 1996) .
The precise mechanisms by which progestins exert their protective effects against ovarian carcinogenesis remain unclear. A handful of studies have demonstrated that progestins inhibit cell growth and/or induce apoptosis in OCa cell cultures (Bu et al., 1997; Hu and Deng, 2000; Keith and Bonavida, 2001; Yu et al., 2001; Syed and Ho, 2003) . Alterations in apoptosis regulators such as bcl-2, c-myc, and p53 were detected in OCa cells undergoing progestin-induced apoptosis (Bu et al., 1997; Hu and Deng, 2000; Athanassiadou et al., 1998) . Relatively high doses of progestins (1 mM range) were used in these studies to achieve growth inhibition and apoptosis. Previously, using semiquantitative RT-PCR, we (Lau et al., 1999) have demonstrated expression of PR mRNA in primary and immortalized cultures of normal human OSE (HOSE) cells. We recently investigated the effects of P4 on normal OSE and on OCa cells across a 6-log concentration range (10 À11 -10 À6 M) and demonstrated a growth promotional effect of P4 at low concentrations (below 10 À8 M) and a growth inhibitory action of P4 at higher concentrations (10 À7 to 10 À6 M) (Syed et al., 2001) . These observations are consistent with the postulate that regenerative proliferation that follows ovulation-induced cell loss, in the OSE, is mediated by luteal phase levels of P4 (Murdoch and McDonnel, 2002) . In contrast, higher doses of P4, in the range experienced during pregnancy or perhaps during oral contraceptive use, consistently induce cell cycle arrest or apoptosis in normal OSE cells and OCa cells. Importantly, we have further demonstrated that a Fas/ FasL-activated caspase-8 pathway is involved in P4-induced apoptosis in both normal OSE and OCa cells . Cell death induced by high doses of P4 may serve to rid the OSE of genetically damaged or altered cells and guard against malignant transformation (Ho, 2003) .
The purpose of this study was to elucidate additional mechanisms through which P4 protects against development of OCa. A cDNA microarray containing 2388 known transcripts, together with the Tyramide Amplification Systemt and t statistics Lau et al., 2003) , were employed to identify genes whose expression are altered after exposure of nontumorigenic human OSE (HOSE) cell lines or OCa (OVCA) cell lines to 10 À 6 M of P4. We then selected those whose expression are (1) lost or significantly reduced in OVCA cell lines when compared to HOSE cell lines and (2) are upregulated by P4 only in the malignant cell lines and not in the nontumorigenic cell lines. Among a pool of candidates, we narrowed our focus to four genes (ATF-3, caveolin-1, DLC-1, and NM23-H2) which, based on literature research, have previously been shown to play a critical role in carcinogenesis. Post hoc studies were conducted to confirm their expression pattern and characterize their biological roles. Although all four genes display antitumorigenic actions, including inhibition of cell growth, reduction of soft agar colony formation, and suppression of cell motility, in OVCA cells their mechanism(s) of action vary. While AFT-3 was shown to be an apoptosis inducer, the antitumor action of NM23-H2 was primarily mediated via restraint of cell motility. In contrast, caveolin-1 and DLC-1 were found to have a broader spectrum of antitumor activities that are consistent with those displayed by bona fide tumor suppressors. In sum, through gene profiling and post hoc functional studies, we have identified four P4-regulated molecular targets that may have high relevance to the prevention and treatment of OCa.
Results
Classification of genes whose expression was altered in all HOSE and OVCA cell lines following P4 treatment
In the three HOSE and three OVCA cell lines, gene expression profiles before hormone treatment were compared to those observed in the same lines after 5 days of P4 treatment. The sets of genes whose expression was threefold altered following hormonal treatment in HOSE cell lines or in OVCA cell lines in a consistent manner were identified by t-statistics analyses as described earlier Lau et al., 2003) . A total of 171 genes were differentially expressed in all three immortalized HOSE cell lines after P4 treatment, and 135 genes were identified as having changed expression in all three OVCA cell lines after P4 exposure (Figure 1) . Among the 171 genes whose expression changed following P4 treatment of HOSE cell lines, 65 (38%) genes were upregulated, and 106 (62%) genes were downregulated. In contrast, of the 135 genes whose expression was affected by P4 in OVCA cell lines, only 55 (40.7%) were upregulated and 80 (59.3%) were downregulated. We have further analysed the genes that were differentially regulated by P4 in the three OVCA cell lines and three HOSE cell lines based on their reported functions in the literature. They could be classified into 13 categories, including genes encoding receptors, signal transduction, protein modification, apoptosis, protein biosynthesis, transcription processing, cell cycle growth differentiation, protein transport, cell adhesion, binding proteins, tumor suppressors, and oncogenes. Genes involved in mRNA transcription and processing seem to form the largest class of genes affected by P4 in both HOSE and OVCA cells. In contrast, P4 appears to affect more genes involved in protein modification, apoptosis, and cell adhesion/ structure/motility in the HOSE cells than in OVCA cells. To further narrow down candidates for functional studies, we have focused on genes whose expression were lost/reduced in OVCA cells (fitting a tumorsuppressor phenotype) but were upregulated by P4 exclusively in OVCA cells (having potential to be molecular targets for P4 therapy). Among this set of genes, we selected ATF-3, caveolin-1, DLC-1 and NM23-H2 for functional studies based on the fact that they have been reported to have antitumor and/or proapoptotic activities in other neoplasms.
Identification of putative antitumor genes whose expression was upregulated by P4 in OVCA cell lines but not in HOSE cell lines
The following criteria were used to identify potential P4-induced antitumor genes from our array data. We first identified genes whose expression was lost or markedly reduced in the three OVCA cell lines when compared to expression in HOSE cells. Thus, these genes fit the phenotype of antitumor genes. From these we then selected genes whose expression was upregulated by P4 in OVCA cell lines but not affected by the hormone in HOSE cell lines. Among a pool of 352 candidates, we narrowed our focus to four genes which, based on literature research, have previously been shown to play a critical role in carcinogenesis. DLC-1, caveolin-1, and NM23-H2 have been reported as tumor/metastasis suppressors for other neoplasms and ATF-3 is a known apoptosis-inducing gene.
RT-PCR was used to amplify fragments of ATF-3, caveolin-1, DLC-1, and NM23-H2 from RNAs of the HOSE and OVCA cells treated either with vehicle or P4 (10 À 6 M). RT-PCR analysis demonstrated lower levels of expression of genes encoding ATF-3, caveolin-1, DLC-1, and NM23-H2 in OVCA cell lines compared to immortalized normal HOSE cell lines (Figure 2a) . Marked increases in ATF-3, caveolin-1, DLC-1, and NM23-H2 gene expression were observed in the three OVCA cell lines exposed to P4, while gene expression was not altered in all HOSE cell lines by P4, hence confirming the pattern of gene expression detected by microarray analyses. The hormone specificity of these genes was validated by the treatment of OVCA cells with the progestin antagonist RU 38486. Exposure of OVCA cell lines to RU 38486 (10 À5 or 10 À4 M) inhibited the P4-induced expression of ATF-3, caveolin-1, DLC-1, and NM23-H2 in a dose-dependent manner (Figure 2b ). RU 38486 alone caused no effect on gene expression (results not shown).
Caveolin-1, DLC-1 and ATF-3, and NM23-H2 transcripts are induced in OVCA cell lines by P4 after 4 and 8 h of culture To study the time-dependent induction of ATF-3, caveolin-1, DLC-1, and NM23-H2, OVCA cells were HOSE 642, , and malignant OSE cell lines (OVCA 420, OVCA 429, and OVCA 432) were treated as described in 'Materials and methods' with P4 (10 À6 M) to isolate total RNA. Semiquantitative RT-PCRs were performed as described in 'Materials and Methods.' Gray and black columns represent the relative abundance of ATF-3, caveolin-1, DLC-1, and NM23-H2 in individual, immortalized, untreated HOSE, and OCa cell lines, respectively. Hatched and Open columns represent the relative abundance of P4-induced ATF-3, caveolin-1, DLC-1, and NM23-H2 in immortalized HOSE and OVCA cell lines, respectively. (b) To confirm the specificity of P4, OVCA cells were cultured alone (Black columns), treated with 10 À6 M of P4 (open columns), or cotreated with two doses of RU 38486 (10 À5 M, 10 À4 M, gray columns) for 5 days. The control cells were treated with vehicle. After 5 days, RNA was extracted and analysed for the expression of ATF-3, caveolin-1, DLC-1, and NM23-H2. Three independent RT-PCRs were performed with total RNA of HOSE and OVCA cell lines. Relative mRNA levels were expressed as arbitrary units derived from signal intensities of ethidium bromide-stained PCR products of the target cDNA normalized to those of GAP-DH cDNA. The data are shown as the means7s.d. Statistically significant difference in the transcript levels in P4-treated cell lines and those observed in untreated cell cultures at Po0.05 are shown Progesterone-regulated, anti-tumor genes for ovarian cancer V Syed et al MTS assay was used to measure cell growth in cells transfected with the empty vector or the targeted vector. A significant reduction in cell number was observed in all three OVCA cell lines transfected with an expression plasmid containing a ATF-3, caveolin-1, DLC-1, or NM23-H2 construct in a 5-day experiment (Figure 5a To determine whether P4 per se exerts growth inhibitory effects on OVCA cell lines, presumably by upregulating ATF3, caveolin-1, DLC-1, and NM23, mock-transfected OVCA cell lines were treated with P4 for 5 days and cell numbers were analysed by the MTS assay ( Figure 5e ). Treatment of mock-transfected OVCA cell lines with P4 resulted in significant reduction in cell numbers in all treated cells transfected with the various empty vectors.
Colony-forming potential of OVCA cells reduced by the ectopic expression of ATF-3, caveolin-1, DLC-1, and NM23-H2
Another feature of malignant cells is that they can grow under anchorage-independent conditions, the most common assay being growth and formation of colonies in soft agar. The malignant potential of OVCA cells was assayed. OVCA cells transfected with expression vector carrying either ATF-3, caveolin-1, DLC-1, or NM23-H2 (1.0 mg ml) showed greatly reduced capacity to form colonies on soft agar compared to cell lines carrying the empty vectors ( Figure 6 ). OVCA control cells or OVCA empty vector-transfected cells showed no differences in colony formation. Furthermore, empty vector-transfected cells treated with P4 also showed reduced colonyformation abilities in soft agar when compared to untreated cells. Nevertheless, the degree of reduction induced by P4 was always smaller than that caused by ectopic expression of the respective gene.
Role of ATF-3, caveolin-1, DLC-1, and NM23-H2 on invasiveness of OVCA cells
The effects of ectopic expression of ATF-3, caveolin-1, DLC-1 or NM23-H2 on the invasiveness of OVCA 420, OVCA 429, and OVCA 432 cell lines were determined by measuring the ability of the transfected cells to pass through a layer of the Matrigel, using invasion chambers as described under Materials and methods. Figure 7 shows that transfection of OVCA cell lines with an expression plasmid containing ATF-3, caveolin-1, DLC-1, or NM23-H2 (1.0 mg ml) produced significant decreases in the invasiveness of these cell lines compared with empty vector-transfected cells. No notable difference was seen between control cells and mock-transfected cells. Additionally, empty vector-transfected OVCA cells treated with P4 showed significant but less dramatic decreases in invasiveness when compared to cells transfected with an expression plasmid of ATF-3, caveolin-1, DLC-1, or NM23-H2. The invasion assays were carried out using three separate chambers for each cell line, and cells were counted in five fields of each filter under Â 200 magnification.
Activation of caspase-3 in HOSE and OVCA cell lines
To investigate whether ATF-3, caveolin-1, DLC-1, or NM23-H2 overexpression activates apoptosis, we measured the activation of caspase-3 in equal numbers of HOSE and OVCA cells by a colorimetric substrate assay. Ectopic expression of ATF-3 increased caspase-3 activity in HOSE and OVCA cell lines (Figure 8 ), whereas overexpression of caveolin-1 or DLC-1 increased caspase-3 activity only in OVCA cell lines. Caspase-3 activity was not affected in HOSE or OVCA cell lines following ectopic expression of NM23-H2 (Figure 8) . In order to demonstrate specificity, the active cell lysates were preincubated with a caspase-3 inhibitor (DEVD) before addition of the substrate. In all instances, DEVD was able to abolish the activation of caspase-3 activity (data not shown).
Discussion
Current investigations have suggested that high levels of P4 may offer protection against development of OCa. This study was aimed at discovering new molecular mechanism(s) through which P4 protects against ovarian carcinogenesis by identifying previously unknown P4-regulated anti-OCa genes using transcriptional profiling and a gene-mining strategy reported previously by our group . We here focused on genes whose expression was downregulated in OCa cell lines when compared to HOSE cell lines and whose expression was upregulated by P4 in OCa cells but not in Figure 4 Detection of human ATF-3, caveolin-1, DLC-1, and NM23-H2 transcripts in total RNA samples from transfected normal immortalized and malignant HOSE cell lines. Total RNA from transfected HOSE and OVCA cell lines was extracted and analysed for the expression of ATF-3, caveolin-1, DLC-1, and NM23-H2 by RT-PCR. A significant difference in the transcript levels in transfected cell lines and those observed in control cell cultures is shown in the figure Progesterone-regulated, anti-tumor genes for ovarian cancer V Syed et al HOSE cells. We rationalize that this gene-mining strategy would identify tumor suppressors or antitumor genes whose loss of expression in OCa cells could be restored by P4; thus providing a mechanism through which this steroid confers protection against OCa. Among the set of candidate genes that fits this profile, ATF-3, caveolin-1, DLC-1, and NM23-H2 were selected for functional studies to confirm their anti-OCa action since these genes have previously been shown to have antitumor and/or apoptosis-inducing action. Post hoc qRT-PCR studies confirmed the unique pattern of gene expression, that is, that their expression is lost or Progesterone-regulated, anti-tumor genes for ovarian cancer V Syed et al markedly suppressed in OVCA cell lines but could be restored by P4 treatment. Importantly, ectopic expression of these genes in OCa cells induced notable antitumor activities that include growth inhibition, suppression of anchorage-independent cell growth, diminution of cell motility, and/or induction of apoptosis measured as activation of caspase-3 activity. Nevertheless, the antitumorigenic actions exhibited by each gene vary, implying that the anti-OCa action of P4 is mediated by upregulation of a plethora of genes that exhibits a broad spectrum of antitumor actions.
One of the P4-regulated, anti-OCa genes is ATF-3, a member of the ATF/cyclic adenosine monophosphate (cAMP)-responsive element-binding protein (ATF/ CREB) family of transcription factors (Wolfgang et al., 2000) . It is a stress-inducible transcriptional repressor that is upregulated in response to many physiological stress signals (Hai et al., 1999; Hai and Hartman, 2001 ). ATF-3 has been shown to be a downstream regulator of the Jun NH(2)-terminal kinase (JNK)-mediated stress kinase signaling pathway (Liang et al., 1996) , which is associated with activation of caspases (Mashima et al., 2001) . In the present study, ATF-3 expression was markedly reduced in OVCA cells compared to HOSE cells but could be restored by P4 treatment in OCa cells.
Ectopic expression of ATF-3 in OVCA or HOSE cell lines was accompanied by an elevation of caspase-3 activity and a reduction in cell numbers, thus implicating induction of apoptosis in the cell cultures. The proapoptotic action of ATF-3 has been demonstrated in other types of cancer cell. For example, treatment of Hela S3 and HT 1080 with chemotherapeutic agents induced concomitant upregulation of ATF-3 and activation of caspases (Mashima et al., 2001 ). Yet, we were the first to show that ATF-3 is proapoptotic in normal and malignant OSE cells, and that the expression of this gene is under P4 regulation.
The second P4-regulated anti-OCa gene is caveolin-1, which is located on human chromosome 7q31.1 (Engelman et al., 1998) . Loss of heterozygosity at this locus has been reported in carcinomas of the ovaries, prostate, stomach, and kidney, suggesting that caveolin-1 could be a universal tumor suppressor (Zenklusen et al., 1994; Nishizuka et al., 1997; Shridhar et al., 1997; Koike et al., 1999) . We observed decreased expression of caveolin-1 in OVCA cell lines. This observation confirms data published by others (Racine et al., 1999; Bender et al., 2000; Wiechen et al., 2001 ) that reported loss of caveolin-1 expression in serous ovarian tumors and that forced expression of the gene in a OCa cell line Progesterone-regulated, anti-tumor genes for ovarian cancer V Syed et al (OVCAR-3) resulted in decreases in cell growth and soft agar colony formation (Wiechen et al., 2001) . In concordance, we found ectopic expression of caveolin-1 in OVCA cell lines significantly reduced cell growth, soft agar colony formation, and cell motility, but increased caspase-3 activity. These findings strongly implicate caveolin-1 as a tumor suppressor of OCa. Significantly, we have provided the first evidence that caveolin-1 expression is under P4 regulation. DLC-1 has been mapped to chromosome 8p21.3-p22 (Yuan et al., 1998) and been regarded as a tumor suppressor gene for cancers of the liver, breast, and stomach (Ng et al., 2000; Kim et al., 2003; Plaumann et al., 2003; Yuan et al., 2003) . Ectopic expression of DLC-1 in a DLC-1-deficient breast cancer cell line or a hepatocellular carcinoma cell line resulted in suppression of in vitro growth and in vivo tumorigenicity in nude mice (Ng et al., 2000; Plaumann et al., 2003; Yuan et al., 2003) . In the present study, overexpression of DLC-1 in OVCA cell lines significantly inhibited cell growth, elevated caspase-3 activity, and reduced both colony formation in soft agar and migration of cells through Matrigel. These findings are consistent with the notion that DLC-1 has tumor suppressor action in OCa cells. To our knowledge, this is the first report that suggested DLC-1 as an OCa suppressor and demonstrated its regulation by P4.
Lastly, NM23-H2, localized on chromosome 17q21.3, has been reported to function as a metastasis suppressor (Fournier et al., 2003) . It controls cell migration and tumor cell metastasis by regulating expression of cell surface integrin receptors and matrix metalloproteases. Although NM23-H2 has been widely investigated as a metastasis suppressor in a great variety of neoplasms, Progesterone-regulated, anti-tumor genes for ovarian cancer V Syed et al studies on OCa are limited. Mandai et al. (1995) reported that OCa patients with metastatic lymph node involvement had lower NM23-H2 expression in their cancers than those with lymph node-negative disease. Tas et al. (2002) found higher levels of NM23-H2 expression to be associated with better prognosis in OCa patients. We found underexpression of NM23-H2 in OVCA cell lines when compared to HOSE cell lines. Ectopic expression of this gene in OVCA cells led to growth inhibition, marked reduction in cell motility, and diminished soft agar colony-formation potential. In contrast to the other three genes mentioned above, overexpression of NM23-H2 in OVCA cells did not induce caspase-3 activation. Together, these findings suggest that the anti-OCa action of NM23-H2 could be primarily due to its metastasis suppressor action rather than induction of apoptosis. Interestingly, our finding that NM23-H2 is under P4 regulation in OCa cells is in agreement with a recent report (Ouatas et al., 2003) demonstrating upregulation of NM23-H1 expression in breast cancer cells and inhibition of their metastatic colonization potential following exposure to medroxyprogesterone acetate. In total, progestins may play a significant role in metastasis suppression by upregulating metastasis suppressors such as NM23s.
The action of P4 is mediated primarily through nuclear progesterone receptors (PRs), which function as ligand-dependent transcription factors belonging to the steroid/thyroid nuclear receptor superfamily (Evans, 1988) . Upon binding of a ligand, PR homodimerizes and the complexes interact with specific DNA sequences known as progesterone response elements (PREs) on the promoter regions of target genes. The latter interaction recruits coregulators and components of the transcriptional machinery to the transcriptional start site, and initiates transcription. In this way, P4 regulates, in a positive or negative manner, expression of unique sets of targeted genes in a target tissue. Such P4-induced transcriptional changes, in turn, lead to activation of additional downstream pathways that define the biological responses. When in silico analyses were conducted using the MatInspector on the promoter regions of the said genes we found putative PREs in all the sequences (unpublished observations). Of interest, the PR gene is transcribed from two different start sites giving rise to two different receptor isoforms: PR-A and PR-B Progesterone-regulated, anti-tumor genes for ovarian cancer V Syed et al (Giangrande et al., 1997) . It has been shown that PR-A and PR-B may exert opposite actions in a target tissue (Cheng et al., 2001; Sartorius et al., 2003; Shao et al., 2003) . Hence, it is not a surprise for us to find, in the present study, a unique set of genes (including AFT-3, caveolin-1, DLC-1, and NM23 H2) that are only upregulated by P4 in the OVCA cells but not in the HOSE cells. The ratios of PR-A to PR-B and transcription factor availability/accessibility differences may be the mechanistic basis for the observed differential regulation of these genes between normal and malignant cells (Giangrande et al., 2000; Xu et al., 2004) . Lastly, it is worthy to note that the regulation of the said genes are not due to the recently cloned membrane PRs (Zhu et al., 2003) , which utilize G proteins as transducers, since increases in the levels of their transcripts in OCa cells did not occur until 4 h (instead of minutes) after exposure to the progestin. The significance of this study is that through transcriptional profiling of P4-regulated genes in multiple normal and malignant OSE cell lines and a hypothesis-based data mining process we have identified four P4-regulated anti-OCa genes. ATF-3 appears to exert its antitumor action via induction of apoptosis, while NM23-H2 acts primarily through suppression of tumor cell invasion. In contrast, DLC-1 and caveolin-1 have a broad spectrum of actions that are consistent with those observed for classical tumor suppressors. Importantly, except for NM23-H2, none of these antiOCa genes have previously been reported to be regulated by progestins. The identification of these new P4 molecular targets in OCa cells offers unique opportunities for future development of novel strategies for OCa therapies.
Materials and methods

Cell cultures and cell lines
We have previously described the origin and culture conditions of nontumorigenic human OSE cell lines (HOSEs) and OCa cell lines (OVCAs) used in this study (Syed et al., 2001 (Syed et al., , 2002 Syed and Ho, 2003) . In short, three HOSE cell lines (HOSE 642, were derived from normal ovaries obtained from women with noncancer gynecologic indications, specifically a 46-year-old healthy woman, a 48-year-old with ovarian inclusion cysts in one ovary, and a 39-year-old patient with ovarian stromal hyperplasia, respectively. Primary cultures were established from surface scrapings of these normal ovaries and immortalized with human papillomavirus E6 and E7 (Tsao et al., 1995) . The immortalized cell lines showed epithelial morphology, cytokeratin staining, no detectable CA125 production, and a lack of in vivo tumorigenicity (Tsao et al., 1995) . Three OVCA cell lines studied (OVCA 429, OVCA 420, and OVCA 432) were previously established cell lines derived from patients with late-stage serous ovarian adenocarcinomas, as described by Bast et al. (1981) . Previously, using semiquantitative RT-PCR, we (Lau et al., 1999) have demonstrated expression of PR mRNA in all HOSE and OVCA cell lines used in this study. These cell lines were cultured at 371C in a humidified atmosphere of 5% CO 2 /95% air in a 1 : 1 mixture of medium 199/MCDB 105 (Sigma, St Louis, MO, USA) supplemented with 10% heat-inactivated fetal bovine serum (HI-FBS; Sigma), penicillin (100 U/ml; Sigma), and streptomycin (100 mg ml; Sigma).
Hormone treatment of HOSE and OVCA cell lines
Cell lines routinely cultured in medium with 10% HI-FBS were harvested when 80% confluent, washed in phosphate-buffered saline (PBS), and seeded at 2 Â 10 5 cells per T-25 flask (Falcon, Becton Dickinson Labware, Bedford, MA, USA; culture area ¼ 25 cm 2 ). After 48 h, the medium was replaced with antibiotic-supplemented medium with charcoal-stripped FBS. Hormone-treated cultures received 10 À6 M P4 (Sigma; final concentration) added as concentrated stock solution in ethanol. Control cultures received the same amount of vehicle without P4. In one set of experiments, two doses of a PR antagonist, RU 38486 (Sigma), were used to block the action of P4. The dosages of the antihormone used were based on literature reports of effective receptor antagonistic effect (Makrigiannakis et al., 2000) . Cell cultures were treated daily for 5 days before they were harvested for total RNA extraction. To study the time-dependent expression of candidate genes, OVCA cells were treated with 10 À6 M P4 for various time periods (10, 20, 30 min. and 1, 2, 4, 8, 18 , and 36 h) before RNA extraction.
RNA isolation, microarray hybridization, and identification of differentially expressed genes
Total RNA was isolated from P4-treated and untreated cultures using the Tri-reagent (Sigma, St. Louis, MO, USA) according to the manufacturer's protocol. RNA integrity was validated according to previously described protocols (Syed et al., 2001 (Syed et al., , 2002 Ho et al., 2003) . The MICROMAXt Tyramide Signal Amplification (TSA) Labeling and Detection kit (Perkin Elmer, CT, USA) was used according to the protocol provided by the manufacturer. Briefly, 4 mg of total RNA from the untreated and P4-treated HOSE/OVCA cell lines were subjected to cDNA synthesis using biotinylated and fluorescein (FL)-labeled nucleotides, respectively, as described previously . Equal quantities of two cDNA probes were mixed and hybridized on a cDNAs microarray slide in a Corning microarray hybridization chamber (Corning Inc., Corning, NY, USA) at 651C overnight. Subsequently, the FL-labeled and biotin-labeled cDNA probes on the slide were recognized by an anti-FL antibody conjugated to horseradish peroxidase (HRP) and streptavidin-linked HRP, respectively. The hybridized microarray slides were scanned using a ScanArrayt confocal laser scanner (GSI Lumonics, Inc., Watertown, CA, USA) at 10 mm pixel resolution for Cy3 and Cy5 signal detection. ImaGene analysis software (BioDiscovery, Inc., Los Angeles, CA, USA) was used to quantify Cy3 and Cy5 signals on each spot. For each spot, average intensity of all pixels within intensity values 50-95% of maximal intensity was calculated (the 'signal intensity'). The 'background signal' was calculated from average intensity of pixels within 5-15% of maximal intensity in the background ring immediately outside the spot of interest on the cDNA microarray. The 'corrected signal intensity' for each spot is calculated as the 'signal intensity' minus the 'background signal'.
Six microarray hybridizations were performed using total RNA samples prepared from P4-treated and untreated cell cultures of three HOSE (HOSE 642, and three OVCA (OVCA 429, OVCA 420, and OVCA 432) cell lines.
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We have used two methods Lyons-Weiler et al., 2003) to identify differentially expressed genes. Before data from the same slide or among different slides could be compared, it was necessary to normalize the data (i.e. remove or adjust for experimental (random) and systematic variations) (Yang et al., 2002) . After within-slide normalization, all normalized log ratios were centered around zero to compare expression levels across different slides; we applied the same normalization principles used for within-slide normalization. In this study, we chose to use all genes for normalization instead of using the microarray housekeeping gene pool for normalization, as explained by Yang et al. (2002) . The global median-intensity method offers the most stability in terms of estimating spatially-and intensity-dependent trends in the log ratios.
Differentially expressed genes associated with treatment of a HOSE/OVCA cell line with P4 were then identified by computing two-sample Welch t statistics as previously described (Callow et al., 2000) . Briefly, the normalized DNA microarray data of gene expression profiles for HOSE (n 1 ¼ 3) and OVCA (n 2 ¼ 3) HOSE/OVCA cell lines were presented as a matrix with columns corresponding to n 1 and n 2 and rows corresponding to the 2400 genes cDNA-spotted on the MICROMAXt microarray slide. The null hypothesis H j of equal mean expression of young and old rats for gene j (j ¼ 1, 2, 3, y , 2400) was tested. For gene j, t-value was calculated as follows:
where w 1j and w 2j denote the mean expression of gene j in HOSE/OVCA cell lines of n 1 untreated and n 2 treated cultures, respectively, and the s 1j 2 and s 2j 2 denote the variances of gene j in HOSE/OVCA cell lines of the n 1 untreated and n 2 treated cultures, respectively. A large absolute t-value was produced by the large differences between two mean values of gene expressions for untreated and P4-treated cultures and/or small variations among the samples within the same group (HOSE or OVCA), suggesting that the corresponding genes were significantly differentially expressed between the treated and the untreated cell cultures of HOSE or OVCA. A high absolute t-score is indicative of high significance in a differentially expressed gene between untreated and treated cell cultures. To assess the evidence against the null hypothesis, the P-value, which is the probability of error associated with rejecting the hypothesis of no difference between the two mean values of gene expression for untreated and treated HOSE/OVCA cell lines, was calculated. Figure 1 was generated by using a previously published analysis method . To further narrow down the gene list, we analysed data and identified dysregulated genes by using the maximum difference subset (MDSS) algorithm as described by Lyons-Weiler et al. (2003) . The advantages of this approach are (1) that it combines classification algorithms, classical statistics, and elements of machine learning, (2) it eliminates the arbitrariness of setting a threshold of statistical significance, and (3) by assimilating prediction accuracy, the MDSS algorithm is able to acquire the critical threshold of statistical significance (Pvalue). Briefly, first t-test was calculated for each gene by comparing normal versus cancer cell lines. Then genes were ranked in descending order according to the magnitude of the t-test. The largest threshold value was found that predicts class membership accurately. Genes beyond the threshold levels were eliminated from the gene list. Then, each sample was left out, one at a time, and the process was repeated. Genes common to all gene lists were retained as the final maximum difference subset. This gene list, comprised of genes that significantly differ between the two groups and, as a group, minimized the classification error rate in sample prediction. The MDSS algorithm is implemented in the online Gene Expression Data Analysis web application caGEDA (http:// bioinformatics.upmc.edu/GE2/GEDA.html) (Patel and Lyons-Weiler, 2004 ).
Confirmation of genes by semiquantitative RT-PCR
Total RNA (1 mg) from each sample was reverse-transcribed using GeneAmp RNA PCR kit (Perkin Elmer, CT, USA). Complementary DNAs derived from RNA samples were stored at À201C until use. To investigate the relative expression levels of ATF-3, caveolin-1, DLC-1, NM23-H2, and glyceraldehyde 3-phosphate dehydrogenase (GAPDH) mRNA in each cell culture, semiquantitative RT-PCRs were performed. The ATF-3 primers were 5 0 -CTCCTGGG TCACTGGTGTTT-3 0 (forward) and 5 0 -GTCGCCTCTTTTT CCTTTCA-3 0 (reverse). Specific caveolin-1 primers were 5 0 -TCTCTACACCGTTCCCATCC-3 0 (forward) and 5 0 -TCCCTTCTGGTTCTGCAATC-3 0 (reverse). For DLC-1, the forward primer was 5 0 -TGTGTGGATGGCCTGTT-TAA-3 0 and the reverse primer was 5 0 -TCCCAGAGG TGCTGTTCTTT-3 0 . The NM23-H2 primers were 5 0 -TGACCTGAAAGACCGACCAT-3 0 (forward) 5 0 -GAAT GATGTTCCTGCCAACC-3 0 (reverse). Specific primers for GAPDH (Das et al., 2000) were 5 0 -CATCACCATCTTC CAGGAGC-3 0 (forward) and 5 0 -GGATGATGTTCTGGA GAGCC-3 0 (reverse). Aliquots of 2 ml of cDNA were subjected to PCR amplification. Hot-start PCR using AmpliTaq Gold DNA polymerase (Perkin-Elmer) was used in all amplification reactions to minimize nonspecific product amplification. The annealing temperatures for amplification of DLC-1 and ATF-3 was 551C, and for caveolin-1, NM23-H2, and GAPDH it was 601C. The number of amplification cycles was 35 for DLC-1, 38 for ATF-3, caveolin-1, and NM23-H2, and 25 for GAPDH. The other conditions were the same, with initial denaturation for 6 min at 941C, cycle denaturation for 1 min at 941C, annealing for 1 min, and extension at 721C for 1 min. The PCR products were fractionated on 2% agarose gel and quantified after ethidium bromide staining. The fluorescence images were visualized under ultraviolet transillumination and captured using a digital camera (Kodak, EDAS 290, Eastman Kodak, Rochester, NY, USA), converted into digitized signals, and intensities of each band quantified by the Kodak 10 Image analysis software version 3.5. (Eastman Kodak). Signal intensities of DLC-1, ATF-3, caveolin-1, and NM23-H2 were normalized to those of GAPDH to produce arbitrary units of relative transcript abundance. The reproducibility of the quantitative measurements was evaluated by three independent cDNA syntheses and PCR runs from each RNA sample. The means of the replicated measurements are shown in figures.
Transfection of HOSE/OVCA cells with expression vectors
The vectors containing DLC-1, caveolin-1, ATF-3, and NM23-H2 were kindly provided by Dr Irene Oi-lin Ng (University of Hong Kong, China), Dr Christine Sers (Charite, Humboldt University, Berlin, Germany), Drs Tetsuo Mashima and Takashi Tsuruo (Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, Tokyo, Japan), and Dr Carl V. Hamby (New York Medical College Valhalla, New York, USA), respectively. À5 cells) were transfected with the pSV-b-galactosidase control vector (Promega, Madison, WI, USA) at 1 mg ml with LipofectAMINE PLUS (Life Technologies, Inc., Rockville, MD, USA). Cells transfected with the pSV-b-galactosidase control vector express b-galactosidase and thus can be identified and used to calculate transfection efficiency as described previously (Syed et al., 2002) . Briefly, after transfection, cells were fixed in glutaraldehyde for 15 min, extensively washed in 1 Â PBS, and incubated with 0.2% X-Gal (5-bromo-4-chloro-3-indolyl b-D-galactopyranoside) in PBS containing 2 mM MgCl 2 , 5mM K 4 Fe(CN) 6 Á 3H 2 O, and 5 mM K 3 Fe(CN) 6 . After fixation and incubation with X-Gal, transfected cells contained a blue reaction product. Transfection efficiencies of HOSE 642, HOSE 6-8, HOSE 12-12, OVCA 420, OVCA 429, and OVCA 432 cells transfected with the pSV-b -galactosidase vector, estimated by X-Gal staining, were 68, 62, 71, 58, 60, and 53%, respectively. After establishing these transfection efficiencies, HOSE 642, HOSE 6-8, HOSE 12-12, OVCA 420, OVCA 429, and OVCA 432 cells were cultured (each at 1 Â 10 5 cells per well) in six-well plates for 24 h. The HOSE and OVCA cell cultures at 60-80% confluency were transfected with the vectors containing ATF-3, DLC-1, caveolin-1, and NM23-H2 (1 mg ml) or their respective empty control vectors (0.5 and 1 mg ml) using Lipofectamine PLUS (Life Technologies, Inc.) in serum-free medium for 3 h at 37 1C, followed by incubation with complete medium for 24 h. In parallel, cells transfected with the empty vectors were treated with 10 À6 M P4 to determine the effects of the steroid alone on the upregulation of the four genes, cell growth, soft agar colony formation, cell migration, and/or caspase-3 activity.
Cell proliferation assay
Cell growth in HOSE or OVCA cells grown in 96-well plates was measured using Promega's Cell Titer Aqueous assay. Viable cells convert MTS tetrazolium to a colored formazan product. In total, 400 ml of the MTS/MPS/medium solution were added to each well, and the plates were incubated for 4 h in a humidified atmosphere. At the end of the incubation period, to determine the cell number in each well, the amount of formazan formed was measured as absorbance at 490 nm in a spectrophotometer. Assays were performed in triplicate to generate mean values. Relative cell growth in cells transfected with a target gene was expressed as fold increases over cells transfected with the respective empty vector. Data points in all figures are group mean values 7s.d.'s from three separate experiments.
Soft agar colony-formation assay
The effects of ectopic expression of ATF-3, caveolin-1, DLC-1, and NM23-H2 on anchorage-independent growth was measured as their abilities to form colonies on soft agar. OVCA 420, OVCA 429, and OVCA 432 were transiently transfected with ATF-3, caveolin-1, DLC-1, and NM23-H2 vectors (1 mg/ ml) or the empty vectors as described above. After 18 h, transfected cells were cultured at 5000 cells per 100-mm plate (four plates per sample) in 0.3% agar above an underlayer of 0.6% Noble agar, both containing complete medium (Freshney, 1994) . In a parallel set of experiments, empty vectortransfected OVCA cells were treated with P4. Plates were incubated for up to 4 weeks and the number of colonies was scored in five fields of each plate to establish the soft agar colony formation potential for each cell line with or without ectopic expression of a transgene. Data shown are the mean7s.d. from four separate plates.
Cell invasion assay
The Biocoat Matrigel Invasion Chambers (Clontech) were used to assess the effects of ectopic expression of a targeted gene on the invasive property of OVCA cells by transient transfection experiments. Matrigel chambers were rehydrated at 371C for 2 h. OVCA cells (2.5 Â 10 4 cells; OVCA 420, OVCA 429, and OVCA 432) transfected with an empty vector or a vector carrying an expression plasmid of ATF3, caveolin-1, DLC-1, or NM23-H2, were seeded in the inserts of the Matrigel Invasion Chambers. In parallel, cultures containing cells transfected with an empty vector were exposed to P4 (10 À6 M). Serum added to the bottom chamber was used as the chemoattractant. At 24 h after plating, noninvading cells were removed from the upper surface of the membrane by scrubbing. The cells on the lower surface of the membrane were fixed for 2 min in 100% methanol and stained in 1% toluidine Blue in 1% sodium borate for 2 min. Excess stain was removed by rinsing the inserts with water. Each membrane was removed from the insert and placed on a microscope slide on which a small drop of immersion oil had been placed. The cover slip was placed on the slide and cells were counted in five random fields per slide. All slides were coded to avoid biased counting. The assay was run in triplicate.
Caspase-3 activity assay
Cells were harvested, pelleted by centrifugation at 400 Â g for 10 min at room temperature, washed once with PBS, and lysed in 50 ml of ice-cold lysis buffer provided with the caspase-3 Assay Kit (BD Biosciences Clontech, Palo Alto, CA, USA). The cell lysates were centrifuged at maximum speed in a microcentrifuge for 3 min at 41C and supernatants transferred to new tubes. In all, 50 ml of a supernatant was added to each well. 2X reaction buffer/DTT Mix 50 ml and 5 ml of 1 mM caspase-3 substrate (DEVD-pNA; 50 mM final concentrations) were added to each reaction and incubated at 371C for 1 h. Increases in absorbance at 405 nm were used to measure caspase-3 activation in the various reactions. To demonstrate specificity, control reactions were carried out by preincubating lysates with a caspase-3 inhibitor, DEVD (30 mM) for 30 min before addition of the caspase-3 substrate.
Statistical analyses
Statistical analysis was carried out using ANOVA, followed by Tukey's post hoc test. Values are presented as the mean7s.d. and are considered significant at Po0.05.
